ARTICLE | Company News

Transgene reorganizes

March 28, 2001 8:00 AM UTC

Transgene (TRGNY; NM:Transgene) said it will focus R&D efforts on its cancer immunotherapy product candidates, and simultaneously announced that Senior Vice President and CSO Michael Courtney will leave the company at the end of the month. Margaret Liu, vice chairman, will oversee TRGNY's scientific strategy. ...